SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bruce Rosen who wrote (6303)4/8/1999 10:18:00 AM
From: Linda Kaplan  Read Replies (1) of 7041
 
If it is true that the shareholder suit was withdrawn or dismissed, perhaps it would be because the stock price was high, so losses couldn't be proven. That does NOT address the merits of the drug or the accuracy of the company's claims.

Do you have a complete copy of the judgment? It seems that only the longs are privy to this information; it has not been published in a press release that we can all see.

As for Asenscio, who cares about him personally? The only people who have mentioned him in this thread in the past year or more have been the longs who bash him.

The issues really are whether the drug has efficacy (seems like it does not), whether it will be approved (it may or may not) and whether it will sell after approved (evidence is that the sales would be negligible).

Meanwhile, maybe just temporarily or maybe permanently, the stock is going down. Last price 18 7/8.

Linda
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext